No abstract available
Keywords:
aromatase inhibitors; exemestane; ovarian suppression; premenopausal breast cancer; tamoxifen.
MeSH terms
-
Androstadienes / pharmacology
-
Androstadienes / therapeutic use*
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Aromatase Inhibitors / pharmacology
-
Aromatase Inhibitors / therapeutic use*
-
Breast Neoplasms / complications*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / mortality
-
Female
-
Humans
-
Obesity / complications*
-
Ovary / drug effects
-
Ovary / metabolism
-
Receptors, Estrogen / metabolism
-
Treatment Outcome
Substances
-
Androstadienes
-
Antineoplastic Agents
-
Aromatase Inhibitors
-
Receptors, Estrogen
-
exemestane